Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,182Revenue (TTM) $M1,023Net Margin (%)14.7Altman Z-Score11.4
Enterprise Value $M22,109EPS (TTM) $0.8Operating Margin %16.4Piotroski F-Score6
P/E(ttm)149Beneish M-Score-1.3Pre-tax Margin (%)15.0Higher ROA y-yY
Price/Book59.910-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsY
Price/Sales22.15-y EBITDA Growth Rate %--Current Ratio3.7Lower Leverage y-yY
Price/Free Cash Flow133y-y EBITDA Growth Rate %2,941ROA % (ttm)12.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)65.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M188ROIC % (ttm)102Gross Margin Increase y-yN

Gurus Latest Trades with INCY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INCYJoel Greenblatt 2016-09-30 Reduce-0.03%$76.11 - $94.29
($84.26)
$ 117.7540%Reduce -24.20%108,099
INCYGeorge Soros 2016-09-30 Reduce-0.01%$76.11 - $94.29
($84.26)
$ 117.7540%Reduce -30.67%5,200
INCYKen Fisher 2016-09-30 Add$76.11 - $94.29
($84.26)
$ 117.7540%Add 0.67%14,917
INCYJoel Greenblatt 2016-06-30 Add0.09%$68.69 - $87.71
($77.54)
$ 117.7552%Add 171.63%142,607
INCYGeorge Soros 2016-06-30 Buy 0.02%$68.69 - $87.71
($77.54)
$ 117.7552%New holding7,500
INCYKen Fisher 2016-06-30 Reduce$68.69 - $87.71
($77.54)
$ 117.7552%Reduce -0.14%14,818
INCYVanguard Health Care Fund 2016-03-31 Add1.06%$63.05 - $108.45
($75)
$ 117.7557%Add 68.76%16,227,748
INCYJoel Greenblatt 2016-03-31 Buy 0.04%$63.05 - $108.45
($75)
$ 117.7557%New holding52,500
INCYGeorge Soros 2016-03-31 Sold Out -0.01%$63.05 - $108.45
($75)
$ 117.7557%Sold Out0
INCYKen Fisher 2016-03-31 Add$63.05 - $108.45
($75)
$ 117.7557%Add 0.14%14,839
INCYVanguard Health Care Fund 2015-12-31 Add0.08%$100.21 - $126.46
($111.45)
$ 117.756%Add 4.15%9,615,828
INCYJoel Greenblatt 2015-12-31 Sold Out -0.01%$100.21 - $126.46
($111.45)
$ 117.756%Sold Out0
INCYGeorge Soros 2015-12-31 Buy 0.01%$100.21 - $126.46
($111.45)
$ 117.756%New holding4,200
INCYKen Fisher 2015-12-31 Add$100.21 - $126.46
($111.43)
$ 117.756%Add 2.23%14,818
INCYVanguard Health Care Fund 2015-09-30 Reduce-0.04%$95.16 - $131.47
($112.12)
$ 117.755%Reduce -1.90%9,233,028
INCYJoel Greenblatt 2015-09-30 Reduce-0.01%$95.16 - $131.47
($112.12)
$ 117.755%Reduce -53.09%4,861
INCYKen Fisher 2015-09-30 Add$95.16 - $131.47
($112.12)
$ 117.755%Add 5.84%14,495
INCYVanguard Health Care Fund 2015-06-30 Reduce-0.15%$88.46 - $110.15
($103.32)
$ 117.7514%Reduce -7.50%9,411,543
INCYJoel Greenblatt 2015-06-30 Buy 0.01%$88.46 - $110.15
($103.32)
$ 117.7514%New holding10,363
INCYKen Fisher 2015-06-30 Reduce$88.46 - $110.15
($103.32)
$ 117.7514%Reduce -7.90%13,695
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INCY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


INCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Huber Reid MEVP, Chief Scientific Officer 2017-01-09Sell11,739$113.553.7view
SWAIN PAULA JEVP, Human Resources 2016-11-15Sell10,000$103.2614.03view
Huber Reid MEVP, Chief Scientific Officer 2016-11-09Sell2,715$109.957.09view
SWAIN PAULA JEVP, Human Resources 2016-10-20Sell10,000$9030.83view
Huber Reid MEVP, Chief Scientific Officer 2016-10-07Sell11,709$96.422.15view
Flannelly Barry PEVP & General Manager US 2016-10-07Sell24,204$9721.39view
SWAIN PAULA JEVP, Human Resources 2016-09-23Sell20,000$9030.83view
Huber Reid MEVP, Chief Scientific Officer 2016-08-02Sell10,000$87.9633.87view
SWAIN PAULA JEVP, Human Resources 2016-07-29Sell60,000$9030.83view
BAKER JULIANDirector, 10% Owner 2016-03-17Buy800,000$63.9884.04view

Quarterly/Annual Reports about INCY:

News about INCY:

Articles On GuruFocus.com
Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions May 03 2016 
Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
Frank Sands Acquires Stake in Netflix Feb 23 2016 
Top Insider Trades of the Past Week Feb 19 2016 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Amazon Among Ken Fisher's Best Performing Stocks Oct 19 2015 
Weekly CFO Sells Highlight: Aramark, Incyte Corp Ltd., Facebook Inc. Jun 09 2014 
Weekly Insider Sells Highlight: ARMK, INCY, ESC, HUN Jun 08 2014 
Weekly Insider Sells Highlight: CPN, INCY, GPK, CODE Feb 23 2014 

More From Other Websites
Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended Jan 16 2017
U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment Jan 13 2017
Merck Carries Incyte On Keytruda Coattails In 4 'Hot' Tumors: Leerink Jan 13 2017
Small Caps Soar, Dow Off; Which Tech Stocks Beat Apple In Gains Today? Jan 10 2017
Incyte/Merck to Start More Epacadostat-Keytruda Studies Jan 10 2017
Jefferies Has 5 Top Biotech Stocks to Buy for 2017 Jan 10 2017
Incyte Stock Breaks Out, It And Partner Merck Will Advance Key Trial Jan 09 2017
Biotech, Chip Stocks Lift Nasdaq To Fresh Closing High Jan 09 2017
Nasdaq hits all-time high Jan 09 2017
Stocks Still Mixed, Medicals Lead Upside; Is Incyte The Next Amgen? Jan 09 2017
Chips Stocks Post Solid Gains As Nasdaq Hits New High Jan 09 2017
Merck Cancer Drug Test Sends Incyte Shares Higher Jan 09 2017
Why These Collaborations Are Important to Incyte Jan 09 2017
Biotech Stocks Surge Monday Amid Flurry of Deal Activity Jan 09 2017
How Was Incyte’s Profitability in 3Q16? Jan 09 2017
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of... Jan 09 2017
What’s in Incyte’s Product Portfolio? Jan 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)